Medicine

HIV deterrence with PrEP in cisgender ladies

.RESEARCH STUDY FEATURE.06 August 2024.

A huge randomized regulated test with cisgender females highlights the challenges of faithfulness to a day-to-day dental preexposure treatment program and displays that twice-yearly shot of lenacapavir can easily maintain successful HIV avoidance degrees over 6 months.